Taken together, these previous results suggest that, as well as microgliosis, inhibition of NLRP3 also reduces astrocytosis in the CNS, consistent with our observations that MCC950 not only inhibited microglia activation but also reduced astrocytosis in HD (Figs. 5, 6). Here, NLRP3 is linked to Huntington disease.